Incyte Corporation Stock News

Economic optimism has broadened the market rally. Small caps had lagged significantly and are now catching-up as they narrow the performance gap. The Federal Re

It's a 144-year-old big pharma...but it's quickly become the leader in a key area of fighting COVID-19.

Roche is licensing out part of its cancer platform to Chinese biotech Innovent Biologics.

Jun 09, 2020 (Market Insight Reports) -- The Ewing Sarcoma Drugs Market report is a compilation of first-hand information, qualitative and quantitative...

Strong economic data propelled stocks higher last week, nearly erasing the entire coronavirus decline. The S&P 500 surged 4.9 percent between Friday, May 29, and Friday, June 7. It was the third strai

Yahoo Finance's Jared Blikre breaks down some of the features of the Yahoo Finance Premium package.

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F

Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Incyte (INCY) reported earnings 30 days ago. What's next for the stock?

Zoom entretient la flamme de Wall Street pour sa valorisation stratosphérique.

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:

Eli Lilly & Co.'s (NYSE: LLY) shares have gained 29% since the beginning of the year and 16% over the past three months.

The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth.